Is there heterozygote expression of growth hormone receptor deficiency?

A. L. Rosenbloom, J. Guevara-Aguirre, Ronald (Ron) Rosenfeld, P. J. Fielder

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Expression of heterozygosity for the defect in the growth hormone (GH) receptor has been proposed to be reflected in stature, and in GH binding protein (GHBP) and insulin-like growth factor I (IGF-I) levels in parents and other relatives of patients with GH receptor deficiency (GHRD; Laron syndrome). The Ecuadorean population with GHRD, in which heterozygosity can be accurately determined in clinically unaffected relatives of probands, offers a unique opportunity to consider this issue. It has previously been demonstrated that 17 parents heterozygous for the Ecuadorean mutation of the GH receptor differed little in biochemical measures (GHBP, IGF-I, IGF-II, IGFBP-2 and IGFBP-3) from Ecuadorean controls. Mean height SDS of 24 non-carrier siblings (-1.3 +/- 0.95 SD) and 41 heterozygote siblings or offspring of probands (-1.8 +/- 1.15) did not differ significantly (p = 0.08). Thus, although there may be slight heterozygote expression of the defective gene for the GH receptor, there is no rationale for counselling based on such minimal variation.

Original languageEnglish (US)
Pages (from-to)125-127
Number of pages3
JournalActa paediatrica (Oslo, Norway : 1992). Supplement
Volume399
StatePublished - Apr 1994
Externally publishedYes

Fingerprint

Laron Syndrome
Heterozygote
Somatotropin Receptors
Insulin-Like Growth Factor I
Siblings
Parents
Insulin-Like Growth Factor Binding Protein 2
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor II
Counseling
Gene Expression
Mutation
Population
somatotropin-binding protein

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Rosenbloom, A. L., Guevara-Aguirre, J., Rosenfeld, R. R., & Fielder, P. J. (1994). Is there heterozygote expression of growth hormone receptor deficiency? Acta paediatrica (Oslo, Norway : 1992). Supplement, 399, 125-127.

Is there heterozygote expression of growth hormone receptor deficiency? / Rosenbloom, A. L.; Guevara-Aguirre, J.; Rosenfeld, Ronald (Ron); Fielder, P. J.

In: Acta paediatrica (Oslo, Norway : 1992). Supplement, Vol. 399, 04.1994, p. 125-127.

Research output: Contribution to journalArticle

Rosenbloom, AL, Guevara-Aguirre, J, Rosenfeld, RR & Fielder, PJ 1994, 'Is there heterozygote expression of growth hormone receptor deficiency?', Acta paediatrica (Oslo, Norway : 1992). Supplement, vol. 399, pp. 125-127.
Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RR, Fielder PJ. Is there heterozygote expression of growth hormone receptor deficiency? Acta paediatrica (Oslo, Norway : 1992). Supplement. 1994 Apr;399:125-127.
Rosenbloom, A. L. ; Guevara-Aguirre, J. ; Rosenfeld, Ronald (Ron) ; Fielder, P. J. / Is there heterozygote expression of growth hormone receptor deficiency?. In: Acta paediatrica (Oslo, Norway : 1992). Supplement. 1994 ; Vol. 399. pp. 125-127.
@article{f03bf30d3c534b808b2734c1ba45db67,
title = "Is there heterozygote expression of growth hormone receptor deficiency?",
abstract = "Expression of heterozygosity for the defect in the growth hormone (GH) receptor has been proposed to be reflected in stature, and in GH binding protein (GHBP) and insulin-like growth factor I (IGF-I) levels in parents and other relatives of patients with GH receptor deficiency (GHRD; Laron syndrome). The Ecuadorean population with GHRD, in which heterozygosity can be accurately determined in clinically unaffected relatives of probands, offers a unique opportunity to consider this issue. It has previously been demonstrated that 17 parents heterozygous for the Ecuadorean mutation of the GH receptor differed little in biochemical measures (GHBP, IGF-I, IGF-II, IGFBP-2 and IGFBP-3) from Ecuadorean controls. Mean height SDS of 24 non-carrier siblings (-1.3 +/- 0.95 SD) and 41 heterozygote siblings or offspring of probands (-1.8 +/- 1.15) did not differ significantly (p = 0.08). Thus, although there may be slight heterozygote expression of the defective gene for the GH receptor, there is no rationale for counselling based on such minimal variation.",
author = "Rosenbloom, {A. L.} and J. Guevara-Aguirre and Rosenfeld, {Ronald (Ron)} and Fielder, {P. J.}",
year = "1994",
month = "4",
language = "English (US)",
volume = "399",
pages = "125--127",
journal = "Acta Paediatrica, International Journal of Paediatrics, Supplement",
issn = "0803-5326",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Is there heterozygote expression of growth hormone receptor deficiency?

AU - Rosenbloom, A. L.

AU - Guevara-Aguirre, J.

AU - Rosenfeld, Ronald (Ron)

AU - Fielder, P. J.

PY - 1994/4

Y1 - 1994/4

N2 - Expression of heterozygosity for the defect in the growth hormone (GH) receptor has been proposed to be reflected in stature, and in GH binding protein (GHBP) and insulin-like growth factor I (IGF-I) levels in parents and other relatives of patients with GH receptor deficiency (GHRD; Laron syndrome). The Ecuadorean population with GHRD, in which heterozygosity can be accurately determined in clinically unaffected relatives of probands, offers a unique opportunity to consider this issue. It has previously been demonstrated that 17 parents heterozygous for the Ecuadorean mutation of the GH receptor differed little in biochemical measures (GHBP, IGF-I, IGF-II, IGFBP-2 and IGFBP-3) from Ecuadorean controls. Mean height SDS of 24 non-carrier siblings (-1.3 +/- 0.95 SD) and 41 heterozygote siblings or offspring of probands (-1.8 +/- 1.15) did not differ significantly (p = 0.08). Thus, although there may be slight heterozygote expression of the defective gene for the GH receptor, there is no rationale for counselling based on such minimal variation.

AB - Expression of heterozygosity for the defect in the growth hormone (GH) receptor has been proposed to be reflected in stature, and in GH binding protein (GHBP) and insulin-like growth factor I (IGF-I) levels in parents and other relatives of patients with GH receptor deficiency (GHRD; Laron syndrome). The Ecuadorean population with GHRD, in which heterozygosity can be accurately determined in clinically unaffected relatives of probands, offers a unique opportunity to consider this issue. It has previously been demonstrated that 17 parents heterozygous for the Ecuadorean mutation of the GH receptor differed little in biochemical measures (GHBP, IGF-I, IGF-II, IGFBP-2 and IGFBP-3) from Ecuadorean controls. Mean height SDS of 24 non-carrier siblings (-1.3 +/- 0.95 SD) and 41 heterozygote siblings or offspring of probands (-1.8 +/- 1.15) did not differ significantly (p = 0.08). Thus, although there may be slight heterozygote expression of the defective gene for the GH receptor, there is no rationale for counselling based on such minimal variation.

UR - http://www.scopus.com/inward/record.url?scp=0028417753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028417753&partnerID=8YFLogxK

M3 - Article

C2 - 7949596

AN - SCOPUS:0028417753

VL - 399

SP - 125

EP - 127

JO - Acta Paediatrica, International Journal of Paediatrics, Supplement

JF - Acta Paediatrica, International Journal of Paediatrics, Supplement

SN - 0803-5326

ER -